Evaluation of the risk of ocular effects associated with eds-flu

Increased intraocular pressure (IOP) and cataracts are known risks of systemic steroid exposure.  EDS-FLU (exhalation delivery system with fluticasone) 372mcg produces higher systemic exposure than fluticasone nasal spray 400mcg, but lower systemic exposure than orally inhaled fluticasone 440mcg.  Ocular effects were extensively studied in EDS-FLU clinical trials.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: D. Skoner, J. Messina, H. Sacks, J. Carothers, R. Mahmoud Tags: P457 Source Type: research